Recent reductions to generic drug prices should go deeper as more generic alternatives become available with the expiration…
Rigor académico, oficio periodístico
Artículos sobre Pharmaceuticals
Mostrando 181 - 200 de 201 artículos
The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
Many pharmaceutical companies are having to re-examine their product portfolio because of the difficult economic climate. New uses for established drugs affords a way for these companies to maximise financial…
It’s the pharmaceutical industry equivalent of the butterfly effect: a drug manufacturing plant in Ohio shuts down production after regulators on two continents uncover contamination problems. Suddenly…
It’s late in the night. And after a long day at work, you have a splitting headache. You rattle around in the bottom drawer of the bathroom vanity to find a packet of paracetamol tablets you know are hiding…
While traces of pharmaceutical compounds are commonly present in wastewater, interactions with bacteria during the treatment…
Two out of three Australians use complementary medicines to boost their nutrition, alleviate various symptoms and improve their overall health and well-being. There are around 10,000 products to choose…
Welcome to “The most powerful companies you’ve never heard of” – an ongoing series from The Conversation that sheds light on big companies with low profiles. Today, Deakin University’s Philip Soos examines…
This week Radio National’s Background Briefing looks at how pharmaceutical companies market their products to doctors. The program is presented by Ray Moynihan, an award-winning journalist, columnist at…
If you took a pill that had been prescribed to treat your illness and it alleviated your symptoms, that means the medicine worked – right? What if you took a complementary medicine from a health food store…
Non-communicable diseases – Philip Soos examines the importance of essential drugs and technologies to the world’s poor, a priority action area noted by the Lancet NCD Action Group and the NCD Alliance…
Personalised medication is one of the ultimate goals of modern medicine although it’s still some way off. But the promise of gender-specific medicines means we may soon be halfway there. In its purest…
Imagine for a moment that you could gain everyone’s trust in an instant – you could sell more, love more and accomplish more than you ever imagined. Or so says the online marketing spiel for the drug oxytocin…
“Would you like the generic brand of that medicine?” It’s a question you’ve probably been asked, or at least heard, when picking up a prescription at your local pharmacy. It’s likely you were told the…
Over the last couple of decades, the pharmaceutical industry has come under attack for its perceived shortcomings amid claims that it’s greedy, profiteering nature has caused significant harm. However…
The latest report on Therapeutic Goods Administration (TGA) activities – this one concerning transparency – has just been made public, two weeks after it was submitted to the government. At least this…
“One of the most exhilarating experiences I know of is performing in public, especially when there is a magnificent piano under my fingers, great music in my head, and the feeling that there are no technical…
In an attempt to contain growing health costs, the Australian Government has resisted recommendations to subsidise the pain medication Targin on the Pharmaceutical Benefits Schedule. Not only is this a…
More than 200 million people are infected annually with the malaria parasite Plasmodium falciparum, and around 800,000 people die every year of the mosquito-borne disease, most of them children. As reported…
The fanfare around Health Minister Nicola Roxon’s announcement yesterday that the government would fund 13 new medicines on the PBS is a reminder of the power and influence involved in the selection and…
Principales colaboradores
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Joel Lexchin es Amigo de The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Lecturer Pharmacy Practice, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
HERA Program Director - Health Workforce Optimisation Centre for the Business & Economics of Health, The University of Queensland
-
Assistant Professor, Bond University
-
PhD Candidate, Swinburne University of Technology
-
Research associate, University of Pretoria
-
Research Fellow, Stellenbosch University
-
Lecturer in Accounting & Management, Lancaster University
-
ARC Future Fellow, Australian National University
-
Purple House Medical Advisor. Honorary ANU., Australian National University
-
Associate Professor, School of Law, University of Canberra
-
Professor of Bioethics, Macquarie University
